Red blood cells generated from human embryonic stem cells may transfuse some life into Advanced Cell Technology

sea-maid submitted, created time 2 months 3 weeks (www.nature.com)

Observers could be forgiven for thinking they had spotted a phoenix rising from the ashes of Advanced Cell Technology (ACT) earlier this week. The Los Angeles, California-based company, which is devoted to turning human embryonic stem cells into therapies, had been reported on the verge of extinction last month after it told the U.S. Securities and Exchange Commission that it would run out of money on 31 July.

However, a recent article in the journal Blood may help prolong the company's life: It has just been shown that red blood cells can and have been created from human embryonic stem cells, boosting ACT's stock price (from $0.04 to $0.06, but I don't think they had much grounds to complain) and brightening its prospects ...a bit.

Keywords: blood transfusions politics stem cell research Advanced Cell Technology red blood cells stem cells embryonic stem cells